Wide Data Gap On Generics Use In Japan Puts Damper On MHLW 30% Generic Target
This article was originally published in PharmAsia News
Executive Summary
TOKYO - A wide data gap on generics penetration between studies commissioned by Chuikyo and the Ministry of Health, Labor and Welfare has surfaced, casting clouds over the Japanese government's official target to raise generics use to 30 percent by 2012
You may also be interested in...
Frustration Drives Japan To Allow Generics Before Side Patents Expire
TOKYO - In a continuing effort to raise generic drug use, Japan's Ministry of Health, Labor and Welfare has decided to allow generic drugs to be manufactured even before brand drugs' side patents expire, the ministry's Insurance Bureau officials said
Frustration Drives Japan To Allow Generics Before Side Patents Expire
TOKYO - In a continuing effort to raise generic drug use, Japan's Ministry of Health, Labor and Welfare has decided to allow generic drugs to be manufactured even before brand drugs' side patents expire, the ministry's Insurance Bureau officials said
Teva-Kowa Faces Uphill Battle With Japanese Domestic And Foreign Generic Drug Makers
Beginning in April, a new joint venture between generic firm Teva and Kowa, a mid-sized Japanese drug maker, will make its official debut in Japan. Aiming to generate ¥100 billion in sales by 2015 and thus becoming the leading generic drug maker in Japan, Teva-Kowa Pharma could drastically change the fast-growing - and yet still lagging - Japanese generic drug market